1. Home
  2. EVGN vs AIMD Comparison

EVGN vs AIMD Comparison

Compare EVGN & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$1.07

Market Cap

9.9M

Sector

Industrials

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.95

Market Cap

10.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGN
AIMD
Founded
1999
1984
Country
Israel
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9M
10.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVGN
AIMD
Price
$1.07
$1.95
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
58.6K
19.6K
Earning Date
03-05-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,016,000.00
$113,037.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.19
178.19
52 Week Low
$0.93
$1.61
52 Week High
$2.42
$4.75

Technical Indicators

Market Signals
Indicator
EVGN
AIMD
Relative Strength Index (RSI) 44.96 47.86
Support Level $1.02 $1.86
Resistance Level $1.10 $1.97
Average True Range (ATR) 0.06 0.12
MACD -0.00 0.04
Stochastic Oscillator 39.29 87.50

Price Performance

Historical Comparison
EVGN
AIMD

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.

Share on Social Networks: